Medinotec (MDNC) Cash from Financing Activities (2022 - 2026)
Medinotec posted quarterly Cash from Financing Activities of -$2531.0 for Q4 2025, up 97.69% year-on-year from -$1280.3 in Q4 2024, and up 99.73% on a QoQ basis from -$942567.0 in Q3 2025.
Medinotec (MDNC) has 4 years of Cash from Financing Activities data on file, last reported at -$2531.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities rose 97.69% year-over-year to -$2531.0; the trailing twelve-month figure through Nov 2025 stood at -$1.0 million (down 81.68% YoY), and the FY2025 full-year result was -$894482.0, down 10953.91% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$2531.0, up from -$942567.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $3.5 million in Q2 2022 and bottomed at -$942567.0 in Q3 2025.
- The 4-year median for Cash from Financing Activities is -$20215.5 (2025), against an average of $123048.2.
- Peak annual rise in Cash from Financing Activities reached 142.05% in 2024, while the deepest fall reached 797.66% in 2024.
- A 4-year view of Cash from Financing Activities shows it stood at $328214.0 in 2022, then sank by 265.58% to -$543453.0 in 2023, then soared by 79.82% to -$109684.0 in 2024, then jumped by 97.69% to -$2531.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$2531.0 (Q4 2025), -$942567.0 (Q3 2025), and -$37900.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Medinotec | - | - | 854,557.00 | 25.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 25.00 |
| Feb 28, 2026 | 25.00 |
| Nov 30, 2025 | -2,531.00 |
| Nov 30, 2025 | -2,531.00 |
| Aug 31, 2025 | -942,567.00 |
| Aug 31, 2025 | -942,567.00 |
| May 31, 2025 | -37,900.00 |
| May 31, 2025 | -37,900.00 |
| Feb 28, 2025 | -50,927.00 |
| Feb 28, 2025 | -50,927.00 |
| Nov 30, 2024 | -109,684.00 |
| Nov 30, 2024 | -109,684.00 |
| Aug 31, 2024 | -192,330.00 |
| Aug 31, 2024 | -192,330.00 |
| May 31, 2024 | -541,541.00 |
| May 31, 2024 | -541,541.00 |
| Feb 29, 2024 | 274,460.00 |
| Feb 29, 2024 | 274,460.00 |
| Nov 30, 2023 | -543,453.00 |
| Nov 30, 2023 | -543,453.00 |
| Aug 31, 2023 | 183,279.00 |
| Aug 31, 2023 | 183,279.00 |
| May 31, 2023 | 77,622.00 |
| May 31, 2023 | 77,622.00 |
| Feb 28, 2023 | -652,644.00 |
| Feb 28, 2023 | -652,644.00 |
| Nov 30, 2022 | 328,214.00 |
| Nov 30, 2022 | 328,214.00 |
| Aug 31, 2022 | 392,323.00 |
| Aug 31, 2022 | 392,323.00 |
| May 31, 2022 | 3.51 Mn |
| May 31, 2022 | 3.51 Mn |
| Feb 28, 2022 | 277,149.00 |
| Feb 28, 2022 | 277,149.00 |